Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IPO performance

IPO performance

U.S.
4Q IPOs Date Raised Post-$ 12/31Mcap Chg
ARYx (NASDAQ:ARYX) 11/7/07 $50.0 $175.4 $135.6 -23%

Read the full 174 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE